Global DNA Methylation Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global DNA Methylation Market Research Report 2024
DNA methylation is an epigenetic mechanism that occurs by the addition of a methyl (CH3) group to DNA, thereby often modifying the function of the genes and affecting gene expression. The most widely characterized DNA methylation process is the covalent addition of the methyl group at the 5-carbon of the cytosine ring resulting in 5-methylcytosine (5-mC), also informally known as the “fifth base” of DNA. These methyl groups project into the major groove of DNA and inhibit transcription.
According to MRA Research’s new survey, global DNA Methylation market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole DNA Methylation market research.
Key companies engaged in the DNA Methylation industry include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck Group, Pacific Biosciences of California, Inc. and PerkinElmer, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of DNA Methylation were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole DNA Methylation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abcam plc
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck Group
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Active Motif, Inc.
Diagenode Diagnostics SA
EpiGentek Group Inc.
New England Biolabs, Inc.
Zymo Research Corporation
Segment by Type
Consumables
Instruments
Software Tools
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The DNA Methylation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRA Research’s new survey, global DNA Methylation market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole DNA Methylation market research.
Key companies engaged in the DNA Methylation industry include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck Group, Pacific Biosciences of California, Inc. and PerkinElmer, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of DNA Methylation were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole DNA Methylation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abcam plc
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck Group
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Active Motif, Inc.
Diagenode Diagnostics SA
EpiGentek Group Inc.
New England Biolabs, Inc.
Zymo Research Corporation
Segment by Type
Consumables
Instruments
Software Tools
Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The DNA Methylation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source